Search results for " Mutation"

showing 10 items of 1212 documents

The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: An ∗IG-IBD study

2004

Hepatologybusiness.industryInflammatory Bowel DiseaseGastroenterologymedicine.diseaseUlcerative colitisFrameshift mutationCrohn DiseaseNOD2ImmunologymedicineCD susceptibilityColitisbusinessAllele frequencyGeneGastroenterology
researchProduct

Hereditäre Pankreatitis - Eine klinisch relevante Ursache des Pankreaskarzinoms? -

2001

UNLABELLED Hereditary pancreatitis is an autosomal dominant disease. Recently, the genetic defect has been mapped to chromosome 7q35 and consists mainly of a point mutation in exon 3 of the cationic trypsinogen gene which causes an Arg(CGC)-His(CAC) substitution at residue 117. In patients with hereditary pancreatitis the estimated cumulative risk for pancreatic carcinoma to age 70 approaches 40 %. Thus, the role of hereditary pancreatitis in the pathogenesis of pancreatic carcinoma is of interest. PATIENTS AND METHODS DNA was extracted from peripheral blood (n = 16), fresh tumor tissue (n = 29) and formalin fixed and paraffin embedded tumor tissue (n = 5) of 50 patients with ductal adenoca…

Hereditary pancreatitismedicine.medical_specialtyTrypsinogenbusiness.industryGeneral surgeryPoint mutationAutosomal dominant traitmedicine.diseasechemistry.chemical_compoundExonmedicine.anatomical_structurechemistryPancreatic cancermedicineCancer researchAdenocarcinomaSurgeryPancreasbusinessZentralblatt für Chirurgie
researchProduct

Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

2021

Key Points Question What genetic variants are associated with juvenile amyotrophic lateral sclerosis (ALS)? Findings In this family-based genetic study, exome sequencing was performed in 3 patients diagnosed with juvenile ALS and failure to thrive; this identified de novo variants in SPTLC1 (p.Ala20Ser in 2 patients and p.Ser331Tyr in 1 patient). Variants in SPTLC1 are a known cause of hereditary sensory and autonomic neuropathy, type 1A, and these data extend the phenotype associated with this gene. Meaning De novo variants in the SPTLC1 gene are associated with juvenile ALS, a fatal neurological disorder.

Hereditary sensory neuropathy; L-serine; Mutations; Deoxysphingolipids; AccumulationEnzyme complexJuvenile amyotrophic lateral sclerosisSerine C-Palmitoyltransferase/dk/atira/pure/subjectarea/asjc/2700/2728Whole Exome Sequencing0302 clinical medicineMedicineFamily historyAmyotrophic lateral sclerosisChildIndex caseExome sequencingOriginal Investigation0303 health sciencesNeurosciences and neurology3. Good healthChild PreschoolFailure to thriveFemalemedicine.symptomLife Sciences & BiomedicineL-SERINECommentsHumanAdultmedicine.medical_specialtyAdolescent; Adult; Amyotrophic Lateral Sclerosis; Child; Child Preschool; Female; Genetic Predisposition to Disease; Humans; Mutation; Serine C-Palmitoyltransferase; Whole Exome Sequencing; Young AdultAdolescentClinical NeurologyNO03 medical and health sciencesYoung AdultDEOXYSPHINGOLIPIDSInternal medicineExome SequencingOnline FirstHumansJuvenileGenetic Predisposition to DiseasePreschool030304 developmental biologyACCUMULATIONScience & TechnologySPTLC1business.industryMUTATIONSResearchAmyotrophic Lateral Sclerosis3112 Neurosciencesmedicine.diseaseHEREDITARY SENSORY NEUROPATHYjuvenileMutation3111 BiomedicineNeurology (clinical)Neurosciences & NeurologyALSgeneticbusiness030217 neurology & neurosurgeryAmyotrophic Lateral Sclerosi
researchProduct

Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots.

2008

Item does not contain fulltext Mutations in NIPA1 cause hereditary spastic paraplegia type 6 (SPG6 HSP). Sequencing of the whole gene has revealed alterations of either of two nucleotides in eight of nine SPG6 HSP families reported to date. By analysing CpG methylation, we provide a mechanistic explanation for a mutational hotspot to underlie frequent alteration of one of these nucleotides. We also developed PCR RFLP assays to detect recurrent NIPA1 changes and screened 101 independent HSP patients, including 45 index patients of autosomal dominant HSP families. Our negative finding in this cohort for which several other causes of HSP had been excluded suggests NIPA1 alterations at mutation…

Hereditary spastic paraplegiaDNA Mutational AnalysisMolecular Sequence DataCohort StudiesDegenerative diseaseCognitive neurosciences [UMCN 3.2]Polymorphism (computer science)DNA Mutational AnalysismedicineHumansGenetic TestingGeneGeneticsbusiness.industrySpastic Paraplegia HereditaryMembrane ProteinsMethylationDNA Methylationmedicine.diseaseNeurologyDNA methylationNeurology (clinical)Restriction fragment length polymorphismbusinessFunctional Neurogenomics [DCN 2]Polymorphism Restriction Fragment LengthJournal of the Neurological Sciences
researchProduct

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

2012

Introduction: Cis-acting regulatory single nucleotide polymorphisms (SNPs) at specific loci may modulate penetrance of germline mutations at the same loci by introducing different levels of expression of the wild-type allele. We have previously reported that BRCA2 shows differential allelic expression and we hypothesize that the known variable penetrance of BRCA2 mutations might be associated with this mechanism. Methods: We combined haplotype analysis and differential allelic expression of BRCA2 in breast tissue to identify expression haplotypes and candidate cis-regulatory variants. These candidate variants underwent selection based on in silico predictions for regulatory potential and di…

HeterozygoteColorectal-cancerPredisposition[SDV.CAN]Life Sciences [q-bio]/CancerSingle-nucleotide polymorphismRegulatory Sequences Nucleic AcidBiologyPolymorphism Single NucleotideAssociation03 medical and health sciences0302 clinical medicineBreast cancerGermline mutation[SDV.CAN] Life Sciences [q-bio]/CancerReference ValuesmedicineHumansGenetic Predisposition to DiseaseAllelic imbalanceGene-expressionAllelePromoter Regions Geneticskin and connective tissue diseases030304 developmental biologyMedicine(all)BRCA2 ProteinGenetics0303 health sciencesHuman genomeCarcinomaHaplotypemedicine.diseasePenetranceCommon3. Good healthGene Expression Regulation NeoplasticMinor allele frequencyGene Expression RegulationHaplotypesRegulatory sequence030220 oncology & carcinogenesisBeadarrayCancer researchFemaleCell-lineTranscription FactorsResearch ArticleBreast Cancer Research
researchProduct

Extremely rapid acclimation of Escherichia coli to high temperature over a few generations of a fed-batch culture during slow warming

2014

This study aimed to demonstrate that adequate slow heating rate allows two strains of Escherichia coli rapid acclimation to higher temperature than upper growth and survival limits known to be strain-dependent. A laboratory (K12-TG1) and an environmental (DPD3084) strain of E. coli were subjected to rapid (few seconds) or slow warming (1 degrees C 12 h(-1)) in order to (re) evaluate upper survival and growth limits. The slow warming was applied from the ancestral temperature 37 degrees C to total cell death 46-54 degrees C: about 30 generations were propagated. Upper survival and growth limits for rapid warming (46 degrees C) were lower than for slow warming (46-54 degrees C). The thermal l…

Hot TemperatureMembrane FluidityAcclimatizationslow warmingBiologymedicine.disease_causeMicrobiologyAcclimatizationProtein Structure SecondaryHot Temperature03 medical and health sciencesAcclimation;Escherichia coli;slow warming;thermal nicheBotanymedicineEscherichia coli[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringEscherichia coliOriginal Research030304 developmental biologyBacteriological Techniques0303 health sciencesStrain (chemistry)030306 microbiologyEscherichia coli ProteinsTotal cellBacterial LoadFed-batch cultureBatch Cell Culture Techniques13. Climate actionBiophysicsThermal limitthermal nicheRandom mutationAcclimation
researchProduct

Amino acid substitutions enhancing thermostability of Bacillus polymyxa beta-glucosidase A

1996

Mutations enhancing the thermostability of β-glucosidase A of Bacillus polymyxa, a family 1 glycosyl hydrolase, have been obtained after hydroxylamine mutagenesis of a plasmid containing the bglA gene, transformation of Escherichia coli with the mutagenized plasmid, and identification of transformant colonies that showed β-glucosidase activity after a thermal treatment that inactivated the wild-type enzyme. Two additive mutations have been characterized that cause replacement of glutamate at position 96 by lysine and of methionine at position 416 by isoleucine respectively. The thermoresistant mutant enzymes showed increased resistance to other denaturing agents, such as pH and urea, while …

Hot TemperatureMutantMolecular Sequence DataBacillusHydroxylamineBiologymedicine.disease_causeHydroxylaminesBiochemistryProtein Structure Secondarychemistry.chemical_compoundHydrolaseEnzyme StabilitymedicineEscherichia coliPoint MutationAmino Acid SequenceCloning MolecularMolecular BiologyEscherichia coliThermostabilitychemistry.chemical_classificationMethionineBase Sequencebeta-GlucosidaseCell BiologyMolecular biologyRecombinant ProteinsAmino acidKineticschemistryBiochemistryOligodeoxyribonucleotidesMutagenesisMutagenesis Site-DirectedThermodynamicsSpectrophotometry UltravioletIsoleucineCysteineResearch Article
researchProduct

Genomics Meets Cancer Immunotherapy

2014

High-throughput cancer genomics and bioinformatics are revolutionizing our ability to profile tumor samples. With next-generation sequencing (NGS) and high-performance computing (HPC) platforms, we have developed the infrastructures to determine and characterize tumor genomes and transcriptomes within days. Now, we are integrating these platforms into both cancer immunology and patient therapy decision-making. Here, we briefly describe the technology platforms and highlight several emerging applications: profiling of tumor mutations and gene expression; determination of HLA type and tumor expression, enabling prediction of immunogenic tumor mutations; and identification of viruses present i…

Human leukocyte antigen typeCancer immunotherapyImmunogenic tumormedicine.medical_treatmentPik3ca mutationmedicineGenomicsHuman leukocyte antigenComputational biologyBiologyGenomeCancer immunology
researchProduct

Differential disease resistance response in the barley necrotic mutant nec1

2010

Abstract Background Although ion fluxes are considered to be an integral part of signal transduction during responses to pathogens, only a few ion channels are known to participate in the plant response to infection. CNGC4 is a disease resistance-related cyclic nucleotide-gated ion channel. Arabidopsis thaliana CNGC4 mutants hlm1 and dnd2 display an impaired hypersensitive response (HR), retarded growth, a constitutively active salicylic acid (SA)-mediated pathogenesis-related response and elevated resistance against bacterial pathogens. Barley CNGC4 shares 67% aa identity with AtCNGC4. The barley mutant nec1 comprising of a frame-shift mutation of CNGC4 displays a necrotic phenotype and co…

Hypersensitive responseGeneticsbiologyMutantfood and beveragesCyclic Nucleotide-Gated Cation ChannelsPseudomonas syringaeBlumeria graminisHordeumPlant SciencePlant disease resistancebiology.organism_classificationImmunity Innatelcsh:QK1-989MicrobiologyFrameshift mutationAscomycotaInteraction with hostlcsh:BotanyPseudomonas syringaeFrameshift MutationPathogenPlant DiseasesPlant ProteinsResearch ArticleBMC Plant Biology
researchProduct

EGFR tyrosine kinase inhibitor therapy continuation with high-dose hypofractionated radiotherapy in EGFR-mutated non-small cell lung cancer (NSCLC) p…

2020

e21580 Background: EGFR tyrosine kinase inhibitors (TKIs) represent the standard first-line therapy for advanced non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, despite initial marked responses, tumors invariably develop acquired resistance to TKIs. Oligoprogression is commonly observed during treatment with oncogene-directed therapies, including EGFR TKIs, and refers to patients who experience disease progression only in limited sites as a result of heterogeneous mechanisms of resistance. The use of local ablative treatments for these resistant lesions may extend the duration of TKI therapy and potentially improve long-term disease control and survival…

Hypofractionated RadiotherapyCancer Researchbusiness.industrynon-small cell lung cancer (NSCLC)Diseasemedicine.diseaseEGFR Tyrosine Kinase Inhibitor TherapyEGFR Tyrosine Kinase Inhibitorsrespiratory tract diseasesOncologyEgfr mutationCancer researchMedicineNon small cellbusinessJournal of Clinical Oncology
researchProduct